• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Agape ATP Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    2/2/26 9:22:23 AM ET
    $ATPC
    Medical/Nursing Services
    Health Care
    Get the next $ATPC alert in real time by email
    false 0001713210 0001713210 2026-01-30 2026-01-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(D)

    OF THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): January 30, 2026

     

    AGAPE ATP CORPORATION

    (Exact name of registrant as specified in its charter)

     

    Nevada   001-41835   36-4838886
    (State or other jurisdiction   (Commission   (IRS Employer
    of incorporation)   File Number)   Identification No.)

     

    1705 – 1708, Level 17, Tower 2, Faber Towers, Jalan Desa Bahagia,
    Taman Desa
    , Kuala Lumpur, Malaysia 58100

    (Address of principal executive offices) (Zip Code)

     

    +(60) 192230099

    (Registrant’s telephone number, including area code)

     

    N/A

    (Former name or former address, if changed since last report.)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, par value $0.0001 per share   ATPC   NASDAQ Capital Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging Growth Company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 5.07 Submission of Matters to a Vote of Security Holders.

     

    On January 30, 2026, Agape ATP Corporation (the “Company”) held its Annual Meeting of Stockholders.

     

    All matters voted on at the Annual Meeting were approved. The voting results were as follows:

     

    1.Ratification of selection of independent registered public accounting firm. The voting results were as follows:

     

    For   Against   Abstain
    30,095,479   50   421

     

    2.By a resolution of members, to approve the re-appointment of five directors, How Kok Choong, Wilfredo Fernando Cortizo, Ramesh Rubin Louis, Ni Luh Dharma Kerti Natih, Rose Marie Kadende Kaiser, each to serve a term expiring at the next annual meeting of stockholders or until their successors are duly elected and qualified. The voting results were as follows:

     

    Directors  Votes For  Withheld Votes  Abstentions 
    How Kok Choong  29,562,792  2,898  421 
    Wilfrendo Fernando Cortizo  29,562,746  2,944  421 
    Ramesh Ruben Louis  29,562,896  2,794  421 
    Ni Luh Dharma Kerti Natih  29,562,839  2,851  421 
    Rose Marie Kadende Kaiseras  29,556,728  8,962  421 

     

    3.To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the potential issuance of shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), having an aggregate offering price of up to $300,000,000 pursuant to a registration statement on Form S-3 (the “S-3 shelf”), which the company intends to file with the securities and exchange commission (“SEC”) following shareholder approval. The voting results were as follows:

     

    For   Against   Abstain
    29,548,622   16,968   521

     

    4.To approve an amendment to the Company’s Articles of Incorporation to effect one or more reverse stock splits of the company’s issued and outstanding Common Stock at any time before the next annual meeting of stockholders of the Company, in aggregate, of up to one-for-five thousand (1:5000), with the timing of any reverse split to be determined by the board in its discretion. The voting results were as follows:

     

    For   Against   Abstain
    29,969,661   125,867   421

     

    5.To approve an amendment to the Company’s articles of incorporation to increase the number of authorized shares of Common Stock from 500,000,000 to 30,000,000,000. The voting results were as follows:

     

    For   Against   Abstain
    30,073,422   22,106   421

     

    2


     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      AGAPE ATP CORPORATION
       
    Date: February 2, 2026 By: /s/ How Kok Choong
      Name:  How Kok Choong
      Title: Chief Executive Officer, President, Director, Secretary and Treasurer (Principal Executive Officer)

     

    3

     

     

    Get the next $ATPC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATPC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ATPC
    SEC Filings

    View All

    SEC Form NT 10-K filed by Agape ATP Corporation

    NT 10-K - Agape ATP Corp (0001713210) (Filer)

    3/31/26 4:20:28 PM ET
    $ATPC
    Medical/Nursing Services
    Health Care

    Agape ATP Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Agape ATP Corp (0001713210) (Filer)

    3/12/26 9:00:25 AM ET
    $ATPC
    Medical/Nursing Services
    Health Care

    Agape ATP Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Agape ATP Corp (0001713210) (Filer)

    3/10/26 9:00:39 AM ET
    $ATPC
    Medical/Nursing Services
    Health Care

    $ATPC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ATPC Expands Global Market Footprint to Spearhead Medical Innovation with MoUs in Indonesia

    Agreements to drive clinical research, enhance product safety, and combat respiratory diseases KUALA LUMPUR, MALAYSIA / ACCESSWIRE / November 29, 2024 / NASDAQ-listed AGAPE ATP Corporation ("ATPC"), today announced the signing of three Memorandums of Understanding ("MOUs") with prominent healthcare institutions in Indonesia. This initiative aims to advance medical research, introduce innovative treatment strategies and strengthen training programs to address respiratory diseases such as tuberculosis (TB) and chronic obstructive pulmonary disease (COPD). The signing marks a key milestone in ATPC's strategic expansion plans in Indonesia and Southeast Asia.(L-R): Dr. Fernando Cortizo, ED, Prof.

    11/29/24 9:00:00 AM ET
    $ATPC
    Medical/Nursing Services
    Health Care

    Agape ATP Corporation - Synergising Innovation Across Business Pillars to Make the World a Better Place

    ATPC Unveils Its Multifaceted Business Pillars to Drive Global Wellness and Sustainability KUALA LUMPUR, MALAYSIA / ACCESSWIRE / October 10, 2024 / NASDAQ-listed AGAPE ATP Corporation ("ATPC"), is proud to present its multifaceted business pillars, each driven by a shared vision to make the world a better place. With a strong commitment to sustainability, health, and enhancing quality of life, ATPC has strategically developed six (6) core pillars that work in synergy to address the world's most pressing challenges, from energy conservation to advanced medical care.ATPC Green Energy ("AGE") spearheads ATPC's efforts in the energy sector, with initiatives aiming to provide sustainable energy s

    10/10/24 9:20:00 AM ET
    $ATPC
    Medical/Nursing Services
    Health Care

    ATPC and FORMEDIC Technologies Announce Strategic Collaboration to Launch LEGA, a Revolutionary Respiratory Care Device

    Innovative Collaboration Brings Advanced Respiratory Solutions to a Global Market KUALA LUMPUR, MALAYSIA / ACCESSWIRE / September 30, 2024 / NASDAQ-listed AGAPE ATP Corporation ("ATPC"), is proud to announce a strategic collaboration with FORMEDIC Technologies Sdn. Bhd. ("FORMEDIC Technologies") to introduce LEGA, an electronic chest percussion device for respiratory care. This partnership marks a major advancement in respiratory health, as the two companies combine their strengths to address the growing demand for advanced respiratory solutions.LEGA, FORMEDIC's flagship product, assists patients with chronic obstructive pulmonary diseases ("COPD"), pneumonia, bronchiectasis, and other lung-

    9/30/24 11:45:00 PM ET
    $ATPC
    Medical/Nursing Services
    Health Care

    $ATPC
    Leadership Updates

    Live Leadership Updates

    View All

    Agape ATP Corporation Announces US$1 Million Share Repurchase Plan

    KUALA LUMPUR, MALAYSIA / ACCESSWIRE / November 22, 2023 / AGAPE ATP Corporation (NASDAQ:ATPC) ("ATPC" or the "Company") announced that its board of directors has authorized a share repurchase plan under which the Company may repurchase up to US$1 million of its shares over the next 6 months. The board of directors have also approved the appointment of Network 1 Financial Securities as the broker to execute the repurchase on behalf of ATPC.The share repurchases may be made from time to time in the open market transactions, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on market conditions and in accordance with applicable secur

    11/22/23 9:00:00 AM ET
    $ATPC
    Medical/Nursing Services
    Health Care